Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

CellOrigin and Qilu to Develop Off-the-Shelf CAR-Macrophage Immunotherapies

publication date: Sep 7, 2022

Hangzhou CellOrigin Biotech will collaborate with Qilu Pharma to develop off-the-shelf chimeric antigen receptor macrophages (CAR-iMAC) using induced pluripotent stem cells (iPSC) for cancer immunotherapy. CellOrigin focuses on immune cell therapies (macrophages, NK cells) based on genetically engineered pluripotent stem cells. It uses metabolomics and transcriptomics analysis together with functional CRISPR-Cas9 screening of iPSCs to create novel allogenic off-the-shelf cell cancer therapies. Founded in 1958, Jinan Qilu offers more than 300 products in China. Both companies will contribute to develop the CAR-iMAC candidates. More details....

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here